SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 139 filers reported holding SERES THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $260,655 | -59.7% | 109,519 | -18.8% | 0.00% | -100.0% |
Q2 2023 | $646,176 | +117.6% | 134,901 | +191.5% | 0.00% | – |
Q3 2022 | $297,000 | -13.4% | 46,286 | -53.7% | 0.00% | – |
Q2 2022 | $343,000 | +63.3% | 100,000 | +296.8% | 0.00% | – |
Q4 2021 | $210,000 | +18.6% | 25,200 | -1.6% | 0.00% | – |
Q3 2021 | $177,000 | +453.1% | 25,600 | +723.7% | 0.00% | – |
Q4 2017 | $32,000 | – | 3,108 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Flagship Pioneering Inc. | 23,117,045 | $110,730,646 | 4.94% |
Lion Point Capital, LP | 691,803 | $3,313,736 | 1.50% |
Eversept Partners, LP | 3,076,756 | $14,737,661 | 1.23% |
Soleus Capital Management, L.P. | 2,045,983 | $9,800,259 | 1.09% |
Knott David M Jr | 470,000 | $2,251 | 0.90% |
GREAT POINT PARTNERS LLC | 938,067 | $4,493,341 | 0.88% |
Simplify Asset Management Inc. | 550,626 | $2,637,499 | 0.35% |
Delphia (USA) Inc. | 33,913 | $162,443 | 0.26% |
Alpha DNA Investment Management LLC | 138,536 | $663,587 | 0.22% |
Avoro Capital Advisors LLC | 2,500,000 | $11,975,000 | 0.16% |